Schedule One - Vulcan Two Group PLC

AI SummaryClose X

Vulcan Two Group plc is seeking admission to AIM, planning a buy-and-build strategy for the UK ePharmacy market. The company has conditionally agreed to acquire CloudRx Holdings Limited, Hyperdrug Pharmaceuticals Ltd, and Webmed Pharmacy Ltd for approximately £41.7 million, funded by a £40 million institutional placing. This constitutes a reverse takeover, subject to shareholder approval. The enlarged company will have an anticipated market capitalization of £54.6 million upon readmission on March 19, 2026, with 27,275,000 ordinary shares. The company aims to consolidate the private prescription sector, leveraging the experience of its management team.

Disclaimer*

UK 100

Latest directors dealings